- 貝達藥業
- 47.480-0.380 (-0.794%)
盈利能力分析
- 5.552
- 7.438
- 6.892
- 3.091
- 8.804
- 3.329
- 4.355
- 4.081
- 2.051
- 6.661
- 3.869
- 5.111
- 4.828
- 2.452
- 7.737
邊際利潤分析
- 80.337
- 81.379
- 83.532
- 88.694
- 92.233
- 14.518
- 13.827
- 10.995
- 3.989
- 17.615
- 16.677
- 14.875
- 14.724
- 11.072
- 17.416
- 11.151
- 13.381
- 13.583
- 5.250
- 16.900
收益指標分析
- 106.134
- 109.486
- 75.225
- -22.028
- 89.133
- -14.796
- -10.394
- -4.244
- -23.545
- 4.094
- -0.745
- -1.450
- 16.147
- -8.251
- -1.455
償債能力分析
- 0.770
- 0.663
- 0.846
- 0.823
- 1.861
- 0.587
- 0.506
- 0.665
- 0.646
- 1.531
- 38.970
- 39.346
- 41.494
- 37.325
- 25.284
- 26.373
- 27.194
- 29.687
- 24.748
- -1.880
- 265.361
- 255.086
- 229.159
- 292.509
- -4,701.270
- 154.591
- 151.645
- 138.352
- 164.239
- 287.637
- 7.358
- 11.940
- 9.136
- 1.499
- 322.094
營運能力分析
- 20.998
- 23.955
- 52.744
- 45.613
- 17.756
- 162.224
- 206.428
- 311.364
- 445.819
- 497.287
大國博弈
貨幣攻略
More